Results 161 to 170 of about 2,052,006 (381)

Collaborating with patients and caregivers to create web-based educational resources for people affected by cirrhosis

PEC Innovation, 2023
Objective: To describe the development of multimodal, web-based educational resources about cirrhosis alongside patients and caregivers. Methods: We used an iterative process that was guided by the Strategy for Patient Oriented Research (SPOR) patient ...
Emily Johnson, Ashley Hyde, Derek Drager, Michelle Carbonneau, Vincent Bain, Jan Kowalczewski, Puneeta Tandon   +6 more
doaj  

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2017
Background Patients with liver cirrhosis have been excluded from randomized clinical trials of oral anticoagulation therapy for stroke prevention in atrial fibrillation.
Ling Kuo, T. Chao, Chia-Jen Liu, Yenn-Jiang Lin, S. Chang, L. Lo, Yu-Feng Hu, Ta-Chuan Tuan, J. Liao, F. Chung, Tzeng-Ji Chen, G. Lip, Shih‐Ann Chen   +12 more
semanticscholar   +1 more source

Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia

American Journal of Hematology, EarlyView.
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT) is the second‐most common inherited bleeding disorder worldwide, afflicting one in 4000–5000 people, and is the most morbid inherited bleeding disorder of women. HHT causes recurrent severe epistaxis, chronic gastrointestinal bleeding, heavy menstrual bleeding, and arteriovenous malformations in the ...
Hanny Al‐Samkari, Tracy J. Mayne, Misty Troutt, Hemant Patle, Marianne Clancy, Eric Duhaime   +5 more
wiley   +1 more source

Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice

Hepatology, EarlyView., 2022
Graphical summary of obesity‐induced NASH progression by LCN2 targeted to HSC activation. Abstract Background and Aims In obesity and type 2 diabetes mellitus, leptin promotes insulin resistance and contributes to the progression of NASH via activation of hepatic stellate cells (HSCs).
Kyung Eun Kim, Jaewoong Lee, Hyun Joo Shin, Eun Ae Jeong, Hye Min Jang, Yu Jeong Ahn, Hyeong Seok An, Jong Youl Lee, Meong Cheol Shin, Soo Kyoung Kim, Won Gi Yoo, Won Ho Kim, Gu Seob Roh   +12 more
wiley   +1 more source

Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study

BMC Gastroenterology
Purpose Hepatocellular carcinoma (HCC) has a poor prognosis, and alpha-fetoprotein (AFP) is widely used to evaluate HCC. However, the proportion of AFP-negative individuals cannot be disregarded.
Chengyu Liu, Zikang Li, Zhilei Zhang, Jinlong Li, Congxi Xu, Yuming Jia, Chong Zhang, Wuhan Yang, Wenchuan Wang, Xiaojuan Wang, Kuopeng Liang, Li Peng, Jitao Wang   +12 more
doaj   +1 more source

Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients

Scientific Reports, 2017
We explored the association between diabetes mellitus (DM) and the risk of hepatitis C virus (HCV)-related liver cirrhosis in Chinese patients with chronic hepatitis C (CHC). To examine the link between DM and liver cirrhosis, we conducted a case-control
Xu Li, Yang Gao, Hongqin Xu, Jie Hou, Pujun Gao   +4 more
doaj   +1 more source

Vitamin B Complex Studies in Dogs: Production of Cirrhosis of Liver [PDF]

, 1943
Paul J. Fouts
openalex   +1 more source

Mortality and Cancer Incidence After Exposure to Blue Asbestos in Childhood: A Further 10 Years of Follow‐Up

American Journal of Industrial Medicine, EarlyView.
ABSTRACT Objectives The impact of early‐life exposure to asbestos on disease risk remains uncertain. Childhood exposure to blue asbestos at Wittenoom has previously been linked to the development of malignant mesothelioma and various cancers in adulthood, as well as to a greater risk of all‐cause mortality compared with the general population.
Renee N. Carey, Alison Reid, Nicholas de Klerk, Peter Cinquini, Nola Olsen, Fraser Brims, Peter Franklin   +6 more
wiley   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

Hepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper   +4 more
wiley   +1 more source

MEGALOBLASTIC ERYTHROPOIESIS IN PATIENTS WITH CIRRHOSIS OF THE LIVER [PDF]

, 1950
E.R. Movitt
openalex   +1 more source